Related Experiment Videos
Autoregulation of interleukin 1 production
J C Manson1, J A Symons, F S Di Giovine
1University of Edinburgh, Rheumatic Diseases Unit, GB.
European Journal of Immunology
|February 1, 1989
Summary
Interleukin 1 (IL 1) production by human cells can increase or decrease based on IL 1 concentration. This concentration-dependent autoregulation of IL 1, a key inflammatory cytokine, has implications for diseases involving excessive IL 1.
Area of Science:
- Immunology
- Cytokine Biology
- Cellular Metabolism
Background:
- Interleukin 1 (IL 1) alpha and beta are critical cytokines involved in immunity, inflammation, and connective tissue metabolism.
- IL 1 production is typically stimulated by microbial products and other cytokines.
- Previous studies suggested that IL 1 might stimulate its own production.
Purpose of the Study:
- To investigate the effect of recombinant IL 1 on the synthesis and release of IL 1 alpha and beta by human blood mononuclear cells (MNC).
- To determine the concentration-dependent nature of IL 1 autoregulation.
Main Methods:
- Human blood mononuclear cells (MNC) were cultured for 20 hours.
- Recombinant IL 1 was added at various concentrations to assess its effect on IL 1 alpha and beta synthesis and release.
- Levels of prostaglandin E2 and interferon-gamma were measured.
- Transforming growth factor beta was added to rule out its involvement.
Main Results:
- Confirmed autoinduction of IL 1 production by recombinant IL 1.
- Demonstrated a significant concentration-dependent effect of IL 1 on its own production.
- Observed inhibition of background IL 1 synthesis at certain IL 1 concentrations.
- Found that the negative feedback was independent of prostaglandin E2 and interferon-gamma levels.
Conclusions:
- IL 1 exhibits previously unrecognized autoregulation, with effects varying by concentration.
- This concentration-dependent feedback mechanism may play a role in diseases characterized by excessive IL 1 production.
- Understanding this autoregulation is crucial for managing inflammatory conditions.